Khan Maaz Ahsan, Bajwa Awais, Hussain Syed Talal
Department of Internal Medicine, University of Oklahoma, Oklahoma City, OK 73104, USA.
Department of Pulmonary, Critical Care & Sleep Medicine, University of Oklahoma, Oklahoma City, OK 73104, USA.
Microorganisms. 2025 Feb 27;13(3):522. doi: 10.3390/microorganisms13030522.
Pneumonia remains a leading cause of mortality internationally, making it an intense area of study for new tools for diagnosis and treatment. In this review, we evaluate the potential of recently emerging syndromic panels in promoting rapid diagnosis and improved antibiotic stewardship. We will also examine emerging treatments, including new antibiotics in a world of worsening antimicrobial resistance, in addition to new methods of delivery and non-antibiotic paths of treatment.
肺炎仍然是全球主要的死亡原因之一，这使其成为诊断和治疗新工具的重点研究领域。在本综述中，我们评估了最近出现的症状组合检测在促进快速诊断和改善抗生素管理方面的潜力。我们还将研究新兴的治疗方法，包括在抗菌药物耐药性日益严重的情况下的新型抗生素，以及新的给药方法和非抗生素治疗途径。
